Panel: All adults should get whooping cough shots

By MIKE STOBBE , AP Medical Writer

A federal advisory panel wants all U.S. adults to get vaccinated against whooping cough.

The panel voted Wednesday to expand its recommendation to include all those 65 and older who haven't gotten a whooping cough shot as an adult.

Children have been vaccinated against whooping cough since the 1940s, but a vaccine for adolescents and adults was not licensed until 2005.

Since then, the Advisory Committee on Immunization Practices has gradually added groups of adults to its recommendations, including 2010 advice that it be given to elderly people who spend a lot of time around infants.

Wednesday's recommendation means now all adults should get at least one dose.

"They've been moving up to this in ," said Dr. William Schaffner, a Vanderbilt University vaccines expert.

Whooping cough, or , is a highly contagious that in rare cases can be fatal. It leads to severe coughing that causes children to make a distinctive whooping sound as they gasp for breath.

Recommendations from the panel are usually adopted by the government, which sends the guidance out to doctors.

Contributing to the push to vaccinate more adults was a California whooping cough epidemic in 2010 that infected 9,000. Ten babies died after exposure to infected adults or older children.

There's little data on how many elderly people have gotten the vaccine. Only about 8 percent of adults under 65 have been vaccinated, but about 70 percent of adolescents have.

believe whooping cough is underreported in , perhaps because in older people the illness can be hard to distinguish from other coughing ailments.

A goal of the recommendation is to prevent teens and adults from spreading the disease to infants, although there's not good evidence this "herd immunity" approach has worked so far. Vaccination for children is included in a series of shots, beginning at 2 months.

The adult vaccine combines protection against tetanus, and whooping cough. One version of the vaccine, made by GlaxoSmithKline, was licensed for use in the elderly last year. The committee said another version, made by Sanofi Pasteur, can also be given. Both cost about $35 a dose.

The shot is as safe as a regular tetanus booster. Estimates range widely for how effective the vaccine is at preventing in older adults, or how much its protection wanes years afterward.

More information: CDC: http://www.cdc.gov/vaccines/recs/ACIP/

not rated yet
add to favorites email to friend print save as pdf

Related Stories

21,000 had whooping cough last year, CDC says

Feb 23, 2011

(AP) -- More than 21,000 people got whooping cough last year, many of them children and teens. That's the highest number since 2005 and among the worst years in more than half a century, U.S. health officials said Wednesday.

Study: Whooping cough vaccination fades in 3 years (Update)

Sep 19, 2011

The whooping cough vaccine given to babies and toddlers loses much of its effectiveness after just three years - a lot faster than doctors believed - and that could help explain a recent series of outbreaks in the U.S. among ...

Recommended for you

Study reveals state of crisis in Canadian foster care system

Oct 24, 2014

A new study of foster care in Canada led by a researcher at Western University reveals a shrinking number of foster care providers are available across the country to care for a growing number of children with increasingly ...

Researchers prove the benefits of persimmons for diet

Oct 24, 2014

Alba Mir and Ana Domingo, researchers from the Department of Analytical Chemistry of the University of Valencia, under the supervision of professors Miguel de la Guardia and Maria Luisa Cervera, from the same department, ...

Hand blenders used for cooking can emit persistent chemicals

Oct 24, 2014

Eight out of twelve tested models of hand blenders are leaking chlorinated paraffins when used according to the suppliers' instructions. This is revealed in a report from Stockholm University where researchers analyzed a ...

User comments